ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/12/18 | 3,735 | 3,795 | 3,735 | 3,790 | +80 | +2.2% | 233,800 |
2017/12/15 | 3,740 | 3,740 | 3,705 | 3,710 | -45 | -1.2% | 183,500 |
2017/12/14 | 3,740 | 3,765 | 3,720 | 3,755 | +30 | +0.8% | 183,500 |
2017/12/13 | 3,735 | 3,760 | 3,720 | 3,725 | +20 | +0.5% | 185,700 |
2017/12/12 | 3,725 | 3,725 | 3,690 | 3,705 | -5 | -0.1% | 232,500 |
2017/12/11 | 3,750 | 3,750 | 3,675 | 3,710 | -10 | -0.3% | 212,400 |
2017/12/08 | 3,650 | 3,720 | 3,650 | 3,720 | +50 | +1.4% | 353,400 |
2017/12/07 | 3,655 | 3,680 | 3,625 | 3,670 | +40 | +1.1% | 252,700 |
2017/12/06 | 3,740 | 3,740 | 3,625 | 3,630 | -120 | -3.2% | 430,800 |
2017/12/05 | 3,750 | 3,760 | 3,700 | 3,750 | -30 | -0.8% | 222,100 |
2017/12/04 | 3,820 | 3,830 | 3,780 | 3,780 | -40 | -1% | 228,000 |
2017/12/01 | 3,900 | 3,900 | 3,810 | 3,820 | -60 | -1.5% | 238,700 |
2017/11/30 | 3,805 | 3,880 | 3,800 | 3,880 | +75 | +2% | 393,300 |
2017/11/29 | 3,815 | 3,815 | 3,790 | 3,805 | ±0 | ±0% | 192,600 |
2017/11/28 | 3,820 | 3,835 | 3,795 | 3,805 | -30 | -0.8% | 286,400 |
2017/11/27 | 3,880 | 3,890 | 3,825 | 3,835 | -35 | -0.9% | 250,100 |
2017/11/24 | 3,865 | 3,880 | 3,850 | 3,870 | -10 | -0.3% | 210,400 |
2017/11/22 | 3,915 | 3,935 | 3,875 | 3,880 | +5 | +0.1% | 366,300 |
2017/11/21 | 3,900 | 3,910 | 3,860 | 3,875 | -45 | -1.1% | 332,400 |
2017/11/20 | 3,940 | 3,940 | 3,905 | 3,920 | -25 | -0.6% | 333,700 |
2017/11/17 | 3,930 | 3,970 | 3,870 | 3,945 | -195 | -4.7% | 1,133,700 |
2017/11/16 | 4,090 | 4,160 | 4,070 | 4,140 | +15 | +0.4% | 251,300 |
2017/11/15 | 4,215 | 4,245 | 4,125 | 4,125 | -130 | -3.1% | 264,600 |
2017/11/14 | 4,320 | 4,370 | 4,245 | 4,255 | -60 | -1.4% | 195,100 |
2017/11/13 | 4,330 | 4,350 | 4,315 | 4,315 | -60 | -1.4% | 195,400 |
2017/11/10 | 4,425 | 4,430 | 4,335 | 4,375 | -100 | -2.2% | 456,000 |
2017/11/09 | 4,480 | 4,615 | 4,450 | 4,475 | +275 | +6.5% | 841,900 |
2017/11/08 | 4,250 | 4,250 | 4,185 | 4,200 | -35 | -0.8% | 232,100 |
2017/11/07 | 4,215 | 4,245 | 4,190 | 4,235 | -5 | -0.1% | 160,900 |
2017/11/06 | 4,240 | 4,245 | 4,200 | 4,240 | +15 | +0.4% | 222,800 |
2017/11/02 | 4,210 | 4,265 | 4,195 | 4,225 | +35 | +0.8% | 231,000 |
2017/11/01 | 4,255 | 4,285 | 4,180 | 4,190 | -20 | -0.5% | 364,900 |
2017/10/31 | 4,250 | 4,255 | 4,190 | 4,210 | -85 | -2% | 328,900 |
2017/10/30 | 4,325 | 4,340 | 4,270 | 4,295 | -30 | -0.7% | 323,000 |
2017/10/27 | 4,270 | 4,325 | 4,250 | 4,325 | +65 | +1.5% | 158,100 |
2017/10/26 | 4,270 | 4,285 | 4,240 | 4,260 | +35 | +0.8% | 155,000 |
2017/10/25 | 4,270 | 4,280 | 4,225 | 4,225 | -40 | -0.9% | 169,500 |
2017/10/24 | 4,260 | 4,285 | 4,240 | 4,265 | +25 | +0.6% | 174,300 |
2017/10/23 | 4,280 | 4,280 | 4,230 | 4,240 | +30 | +0.7% | 144,500 |
2017/10/20 | 4,210 | 4,220 | 4,180 | 4,210 | +15 | +0.4% | 158,000 |
2017/10/19 | 4,210 | 4,230 | 4,185 | 4,195 | -15 | -0.4% | 165,700 |
2017/10/18 | 4,180 | 4,210 | 4,155 | 4,210 | +25 | +0.6% | 134,000 |
2017/10/17 | 4,250 | 4,250 | 4,175 | 4,185 | -60 | -1.4% | 252,200 |
2017/10/16 | 4,220 | 4,270 | 4,220 | 4,245 | +10 | +0.2% | 218,400 |
2017/10/13 | 4,230 | 4,255 | 4,220 | 4,235 | -5 | -0.1% | 232,000 |
2017/10/12 | 4,260 | 4,280 | 4,235 | 4,240 | -10 | -0.2% | 186,300 |
2017/10/11 | 4,230 | 4,295 | 4,215 | 4,250 | +20 | +0.5% | 276,400 |
2017/10/10 | 4,105 | 4,240 | 4,105 | 4,230 | +145 | +3.5% | 460,000 |
2017/10/06 | 4,100 | 4,100 | 4,055 | 4,085 | +10 | +0.2% | 168,600 |
2017/10/05 | 4,065 | 4,100 | 4,050 | 4,075 | +15 | +0.4% | 198,100 |
1801~
1850
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 433,100円 | +20.9% | +87.3% | 3.14% | 9.67倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 435,700円 | +5.8% | +1.2% | 2.75% | 14.45倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 92,200円 | +26.8% | - | 0.00% | 15.52倍 | 3.21倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 189,400円 | +5.0% | +1.5% | 0.00% | 16.26倍 | 4.33倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 341,400円 | +7.9% | +8.9% | 3.63% | 7.30倍 | 0.98倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム